USPSTF Releases Study Proposal for Pancreatic Cancer Screening

Share this content:
The US Preventative Services Task Force released a proposed plan for conducting a systematic review of pancreatic cancer screening.
The US Preventative Services Task Force released a proposed plan for conducting a systematic review of pancreatic cancer screening.

The US Preventative Services Task Force (USPSTF) has released a proposed plan for conducting a systematic review of pancreatic cancer screening.1

The proposed plan aims to answer questions about whether pancreatic cancer screening can improve associated morbidity or mortality and all-cause mortality among the general population or subpopulations.

The study will also address the diagnostic accuracy as well as the potential harms of screening and the resulting treatment.

The plan proposes to include adults with or without risk factors for pancreatic cancer in very high resource settings. The screening tests that will be assessed will be imaging modalities but not serum, stool, or saliva-based biomarkers.

The study will evaluate outcomes related to pancreatic cancer detected with and without screening, as well as outcomes associated to harms of screening and treatment of screening-detected disease.

RELATED: ASCO Updates Potentially Curable Pancreatic Cancer Guideline

Fair to good quality studies, including randomized controlled trials, cohort studies, and case-control studies, will be included from 2002 to present.

Public comments are accepted at the USPSTF website until May 24, 2017, and can be accessed here.

Reference

  1. Draft Research Plan: Pancreatic Cancer: Screening. US Preventive Services Task Force. April 2017. 
  2. https://www.uspreventiveservicestaskforce.org/ Page/Document/draft-research-plan/pancreatic-cancer-screening1. Accessed April 27, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters